LD

Liz Dallimore

Argenica Therapeutics Limited | Chief Executive Officer, Managing Director
Dr Dallimore is a research & development, innovation and commercialsation specialist with over 20 years of experience across Australia and the UK. Prior to joining Argenica Therapeutics, Dr Dallimore was the Director of the WA Data Science Innovation Hub, tasked with working across WA businesses to establish data science projects. Dr Dallimore has also held senior roles in management consulting across Australia, most recently as KPMG's National Director of Research Engagement and Commercialisation.

Company and Roles

Company
Title
Tenure
Since
AGN
AGN
Argenica Therapeutics Limited
  • Chief Executive Officer
  • Managing Director
2yrs, 2mthApr 2022

Holding

Company
Last Notice
Direct Shares
Indirect Shares
Options
Convertibles
AGN
AGN
Argenica Therapeutics Limited
30/06/23N/A50,0004,500,000N/A

Transactions

Company
Date
Type
Amount
Price
Value
Notes
AGN
AGN
Argenica Therapeutics Limited
30/11/22
Issued
2,000,000$0.535$1,070,000Issued under employee share plan
AGN
AGN
Argenica Therapeutics Limited
14/06/22
Buy
10,916$0.400$4,366On-market trade
AGN
AGN
Argenica Therapeutics Limited
10/06/22
Buy
39,084$0.400$15,633On-market trade